TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo

Glioblastomas (GBM) are characterized by resistance to chemotherapy and radiotherapy, and therefore, alternative therapeutic approaches are needed. TRAIL induces apoptosis in cancer but not in normal cells and is considered to be a promising anti-tumor agent. However, its short in vivo half-life and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Perlstein, Benny, Finniss, Susan A., Miller, Cathie, Okhrimenko, Hana, Kazimirsky, Gila, Cazacu, Simona, Lee, Hae Kyung, Lemke, Nancy, Brodie, Shlomit, Umansky, Felix, Rempel, Sandra A., Rosenblum, Mark, Mikklesen, Tom, Margel, Shlomo, Brodie, Chaya
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2013
Ämnen:
Basic and Translational Investigations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534416/
https://ncbi.nlm.nih.gov/pubmed/23144078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos248
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk